Description
A melanocortin receptor agonist (derived from MT-II) approved for treating female hypoactive sexual desire disorder[13]. It stimulates MC4 receptors in the brain to enhance sexual desire and arousal. In research, PT-141 has demonstrated the ability to induce erections in males and increase libido in both sexes[14]. It does not act on the vascular system like PDE5 inhibitors, but through the CNS. Used as a nasally or injectable peptide in studies of sexual dysfunction (with notable efficacy in certain female populations).




Reviews
There are no reviews yet.